Metin Kurtoglu sold $1.4M of Cartesian Therapeutics (RNAC)

Executed Nov 14 2024, disclosed Nov 18 2024, 4 days later.

Value, as filed

$1.4M

78,368 sh across 4 lots

Executed

Nov 14 2024

the trade date, as filed

Disclosed

Nov 18 2024

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

MK Metin Kurtoglu Chief Technology Officer profile →

Metin Kurtoglu (Chief Technology Officer) filed 3 Form 4 reports in the past 24 months (0 purchases, 3 sales), most often in RNAC. The largest single filing was $1.4M of RNAC (78,368 sh across 4 lots, as filed), executed Nov 14 2024.

The name

RNAC RNAC RNAC · 14 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Metin Kurtoglu in RNAC

RNACSALE Cartesian Therapeutics, Inc. $274K
10,763 sh across 2 lots
Exec Dec 9 2024
Filed Dec 11 2024 · 5:30 PM ET RNACSALE Cartesian Therapeutics, Inc. $547K
32,789 sh × $16.67
Exec Nov 21 2024
Filed Nov 21 2024 · 5:30 PM ET